Navigation Links
Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
Date:4/13/2013

New York, New York (PRWEB) April 13, 2013

As Mirena lawsuits continue to move forward in both state and federal courts, Bernstein Liebhard LLP notes that a new Mirena side effects study has found that the bleeding and spotting that sometimes occurs in the months after insertion of the levonorgestrel-releasing IUD (sold under the brand name Mirena) could not be relieved with medication. The study, published online April 5 in Obstetrics & Gynecology, was designed to identify a 25% reduction in the number of bleeding or spotting days for the first 3 months following insertion of the IUD. However, the study found that the administration of one of two drugs commonly used to treat heavy menstrual bleeding and menstrual pain only reduced the number of bleeding days by six and three, respectively.*

“This study is just another reminder of the Mirena side effects that can occur in women who use this IUD. In addition to the bleeding described in this report, our Firm has heard from numerous women who allegedly suffered more serious complications, including organ damage, infections and other problems associated with the spontaneous migration of a Mirena IUD,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to women who suffered serious Mirena side effects, including uterine perforations, stemming from the migration of Mirena.

Mirena IUD Lawsuits
The Mirena IUD was approved by the U.S. Food & Drug Administration (FDA) for contraception in 2000, and in 2009, for the treatment of heavy menstrual bleeding in women who wish to use an IUD as their method of birth control.** The small, plastic t-shaped device is inserted into the uterus by a healthcare provider, where it may remain for up to 5 ye
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
2. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
3. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
4. d’Oliveira & Associates Issues Webpage With Current Information On Mirena IUD Lawsuits
5. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
6. Bernstein Liebhard LLP Launches Mirena IUD Lawsuit Website Providing Information on Side Effects, Growing Litigation
7. DrugRisk Announces Updated Information on Mirena Lawsuits
8. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
9. Zoloft Lawsuits: Bernstein Liebhard LLP Notes More than 300 Claims Now Pending in Federal Zoloft Birth Defects Litigation
10. Medtronic Infuse Bone Graft Lawsuits: Bernstein Liebhard LLP Notes New Report Predicting Hundreds of Medtronic Infuse Lawsuits
11. Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... innovative tool that captures heretofore hidden ways that cells ... protein that makes breast cancer cells more likely to ... cancer,s spread in part by blocking two other proteins ... suggests these two disease processes could have unexpected ties. ... 10 issue of Nature , points to the ...
(Date:7/9/2014)... in Russia might contribute to HIV transmission and ... researchers from Boston University Schools of Medicine and ... State University, sought to discover the effect police ... cohort of HIV-positive people with lifetime of injection ... police were more likely to share needlesincreasing HIV ...
(Date:7/9/2014)... YORK (July 8, 2014) Researchers from Montefiore ... of Medicine of Yeshiva University will present new ... held July 12 July 17 in Copenhagen, Denmark. ... that could prompt transition from cognitive normality to mild ... the Einstein Aging Study , established in 1980 ...
(Date:7/9/2014)... most important organs in the human body. Its job ... this is its synthesis function and that ... is its detoxification function. Lack of exercise and too ... liver. The resulting diseased cells can lead to inflammations, ... According to the German Liver Foundation, over five million ...
(Date:7/9/2014)... Qubec City, July 9, 2014 A study published ... Yves De Koninck and Robert Bonin, two researchers at ... pain hypersensitivity using a new method that involves rekindling ... discovery could lead to novel means to alleviate chronic ... at Universit Laval and Institut universitaire en sant mentale ...
Breaking Medicine News(10 mins):Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2
... screening to identify lung tumors likely to respond ... drugs as first-line treatment rather than after standard ... Massachusetts General Hospital Cancer Center investigators found that ... for non-small-cell-lung-cancer (NSCLC), additional research is required before ...
... the ... chance to change people,s lives, OTTAWA, May 20 ... for new ways to make the most of their,time, especially ... independent marketing opportunities provided by,Melaleuca, The Wellness Company(R)., One ...
... May 20 Wednesday, May 21, 2008,Easter Seals Greater ... Mary Landrieu and Capital One for,their efforts on behalf ... Awards Benefit will be held at the JW Marriott ... and dinner at 7:00,pm. Gordon Peterson of WJLA TV ...
... per patient , , TUESDAY, May 20 (HealthDay News) ... latent tuberculosis saves time, money and lives, new research ... of four months of Rifampin instead of the current ... health-care system," lead analyst Anne Aspler, of the respiratory ...
... May 20 The retiring baby boomers,have challenged ... Moreover, the multi-generational workforce is challenging,companies across all ... to define a new type of leader., ... new thinking,around leadership models, discover fast-acting tactics and ...
... idiopathic pulmonary fibrosis (IPF) may have a new treatment ... Phase III, double-blind, placebo-controlled clinical trial, the investigators discovered ... progression of IPF, reducing the loss of lung capacity. ... Societys 2008 International Conference in Toronto on Tuesday, May ...
Cached Medicine News:Health News:Determining genetic signature of lung tumors can help guide treatment 2Health News:Determining genetic signature of lung tumors can help guide treatment 3Health News:Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R) 2Health News:New Latent TB Drug Saves Lives, Money 2Health News:Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrow's Leaders 2Health News:New treatment gives hope for pulmonary fibrosis patients 2
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North ... sellers of high-value chemistry, will hold the 30 th ... Beach Convention Center from January 21-24. ... attendees from top pharmaceutical, fine chemical and specialty chemical companies ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... Reportlinker.com announces that a new market research report ... Merger and Acquisition Terms and Agreements in ... http://www.reportlinker.com/p0306576/Merger-and-Acquisition-Terms-and-Agreements-in-Pharma-Biotech-and-Diagnostics-4th-edition.html ... analysis of how and why companies enter merger ...
... Oct. 7 Sunridge International (OTC Bulletin Board: ... Trabeculoplasty (PNT) non-invasive treatment for glaucoma and ocular hypertension, ... by Beijing Vision World Trading Co. Ltd. (BVW), in ... patient research studies before gaining regulatory approval by China,s ...
Cached Medicine Technology:Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 2Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 3Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 4Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 5Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 6Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 7Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition 8Sunridge Advances its PNT Glaucoma Treatment Throughout China 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: